Title : Sequential treatment with aurora B inhibitors enhances cisplatin-mediated apoptosis via c-Myc.

Pub. Date : 2015 Apr

PMID : 25411027






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Sequential treatment with aurora B inhibitors enhances cisplatin-mediated apoptosis via c-Myc. Cisplatin MYC proto-oncogene, bHLH transcription factor Homo sapiens
2 Thus, our report reveals for the first time that sequential treatment of Aurora B inhibitors and cisplatin is essential to inhibit ovarian carcinoma by inducing polyploidy and downregulating c-Myc and that c-Myc is identified as a predictive biomarker to select cells responsive to chemotherapeutical combinations targeting Aurora B. Cisplatin MYC proto-oncogene, bHLH transcription factor Homo sapiens
3 Thus, our report reveals for the first time that sequential treatment of Aurora B inhibitors and cisplatin is essential to inhibit ovarian carcinoma by inducing polyploidy and downregulating c-Myc and that c-Myc is identified as a predictive biomarker to select cells responsive to chemotherapeutical combinations targeting Aurora B. Cisplatin MYC proto-oncogene, bHLH transcription factor Homo sapiens
4 The synergy of Aurora B inhibitor with cisplatin is dependent on c-Myc expression. Cisplatin MYC proto-oncogene, bHLH transcription factor Homo sapiens
5 c-Myc-dependent induction of polyploidy sensitizes cells to cisplatin. Cisplatin MYC proto-oncogene, bHLH transcription factor Homo sapiens